Positive and negative regulators of the metallothionein gene (Review)

Takahashi,Shinichiro

doi:10.3892/mmr.2015.3459

Positive and negative regulators of the metallothionein gene (Review)

Authors:
- Shinichiro Takahashi
View Affiliations

Affiliations: Division of Molecular Hematology, Kitasato University Graduate School of Medical Sciences and Division of Hematology, Kitasato University School of Allied Health Sciences, Sagamihara, Kanagawa 252‑0373, Japan
Published online on: March 9, 2015 https://doi.org/10.3892/mmr.2015.3459
Pages: 795-799

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Metallothioneins (MTs) are metal‑binding proteins involved in diverse processes, including metal homeostasis and detoxification, the oxidative stress response and cell proliferation. Aberrant expression and silencing of these genes are important in a number of diseases. Several positive regulators of MT genes, including metal‑responsive element‑binding transcription factor (MTF)‑1 and upstream stimulatory factor (USF)‑1, have been identified and mechanisms of induction have been well described. However, the negative regulators of MT genes remain to be elucidated. Previous studies from the group of the present review have revealed that the hematopoietic master transcription factor, PU.1, directly represses the expression levels of MT genes through its epigenetic activities, and upregulation of MT results in the potent inhibition of myeloid differentiation. The present review focuses on PU.1 and several other negative regulators of this gene, including PZ120, DNA methyltransferase 3a with Mbd3 and Brg1 complex, CCAAT enhancer binding protein α and Ku protein, and describes the suppression of the MT genes through these transcription factors.

View Figures

View References

1	Takahashi S: Molecular functions of metallothionein and its role in hematological malignancies. J Hematol Oncol. 5:412012. View Article : Google Scholar : PubMed/NCBI
2	Hamer DH: Metallothionein. Annu Rev Biochem. 55:913–951. 1986. View Article : Google Scholar : PubMed/NCBI
3	Cherian MG, Jayasurya A and Bay BH: Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res. 533:201–209. 2003. View Article : Google Scholar : PubMed/NCBI
4	Datta J, Majumder S, Kutay H, et al: Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade. Cancer Res. 67:2736–2746. 2007. View Article : Google Scholar : PubMed/NCBI
5	Yan DW, Fan JW, Yu ZH, et al: Downregulation of metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue. Biochim Biophys Acta. 1822:918–926. 2012. View Article : Google Scholar : PubMed/NCBI
6	Wei H, Desouki MM, Lin S, Xiao D, Franklin RB and Feng P: Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues. Mol Cancer. 7:72008. View Article : Google Scholar : PubMed/NCBI
7	Theocharis SE, Margeli AP, Klijanienko JT and Kouraklis GP: Metallothionein expression in human neoplasia. Histopathology. 45:103–118. 2004. View Article : Google Scholar : PubMed/NCBI
8	Ofner D, Maier H, Riedmann B, et al: Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumour stage and patient survival. Virchows Arch. 425:491–497. 1994. View Article : Google Scholar : PubMed/NCBI
9	Zhang B, Satoh M, Nishimura N, et al: Metallothionein deficiency promotes mouse skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene. Cancer Res. 58:4044–4046. 1998.PubMed/NCBI
10	Poulsen CB, Borup R, Borregaard N, Nielsen FC, Møller MB and Ralfkiaer E: Prognostic significance of metallothionein in B-cell lymphomas. Blood. 108:3514–3519. 2006. View Article : Google Scholar : PubMed/NCBI
11	Bay BH, Jin R, Huang J and Tan PH: Metallothionein as a prognostic biomarker in breast cancer. Exp Biol Med (Maywood). 231:1516–1521. 2006.
12	Shukla VK, Aryya NC, Pitale A, et al: Metallothionein expression in carcinoma of the gallbladder. Histopathology. 33:154–157. 1998. View Article : Google Scholar : PubMed/NCBI
13	Weinlich G, Eisendle K, Hassler E, Baltaci M, Fritsch PO and Zelger B: Metallothionein-overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients. Br J Cancer. 94:835–841. 2006. View Article : Google Scholar : PubMed/NCBI
14	You HJ, Lee KJ and Jeong HG: Overexpression of human metallothionein-III prevents hydrogen peroxide-induced oxidative stress in human fibroblasts. FEBS Lett. 521:175–179. 2002. View Article : Google Scholar : PubMed/NCBI
15	Surowiak P, Materna V, Maciejczyk A, et al: Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome. Virchows Arch. 450:279–285. 2007. View Article : Google Scholar : PubMed/NCBI
16	Imoto A, Okada M, Okazaki T, Kitasato H, Harigae H and Takahashi S: Metallothionein-1 isoforms and vimentin are direct PU.1 downstream target genes in leukemia cells. J Biol Chem. 285:10300–10309. 2010. View Article : Google Scholar : PubMed/NCBI
17	Suzuki S, Nakano H and Takahashi S: Epigenetic regulation of the metallothionein-1A promoter by PU.1 during differentiation of THP-1 cells. Biochem Biophys Res Commun. 433:349–353. 2013. View Article : Google Scholar : PubMed/NCBI
18	Ghoshal K and Jacob ST: Regulation of metallothionein gene expression. Prog Nucleic Acid Res Mol Biol. 66:357–384. 2001.
19	Laukens D, Waeytens A, De Bleser P, Cuvelier C and De Vos M: Human metallothionein expression under normal and pathological conditions: mechanisms of gene regulation based on in silico promoter analysis. Crit Rev Eukaryot Gene Expr. 19:301–317. 2009. View Article : Google Scholar : PubMed/NCBI
20	Haq F, Mahoney M and Koropatnick J: Signaling events for metallothionein induction. Mutat Res. 533:211–226. 2003. View Article : Google Scholar : PubMed/NCBI
21	Radtke F, Heuchel R, Georgiev O, et al: Cloned transcription factor MTF-1 activates the mouse metallothionein I promoter. EMBO J. 12:1355–1362. 1993.PubMed/NCBI
22	Palmiter RD: Regulation of metallothionein genes by heavy metals appears to be mediated by a zinc-sensitive inhibitor that interacts with a constitutively active transcription factor, MTF-1. Proc Natl Acad Sci USA. 91:1219–1223. 1994. View Article : Google Scholar : PubMed/NCBI
23	Andrews GK, Lee DK, Ravindra R, et al: The transcription factors MTF-1 and USF1 cooperate to regulate mouse metallothionein-I expression in response to the essential metal zinc in visceral endoderm cells during early development. EMBO J. 20:1114–1122. 2001. View Article : Google Scholar : PubMed/NCBI
24	LaRochelle O, Labbe S, Harrisson JF, et al: Nuclear factor-1 and metal transcription factor-1 synergistically activate the mouse metallothionein-1 gene in response to metal ions. J Biol Chem. 283:8190–8201. 2008. View Article : Google Scholar : PubMed/NCBI
25	Westin G and Schaffner W: A zinc-responsive factor interacts with a metal-regulated enhancer element (MRE) of the mouse metallothionein-I gene. EMBO J. 7:3763–3770. 1988.PubMed/NCBI
26	Dalton T, Palmiter RD and Andrews GK: Transcriptional induction of the mouse metallothionein-I gene in hydrogen peroxide-treated Hepa cells involves a composite major late transcription factor/antioxidant response element and metal response promoter elements. Nucleic Acids Res. 22:5016–5023. 1994. View Article : Google Scholar : PubMed/NCBI
27	Murphy BJ, Andrews GK, Bittel D, et al: Activation of metallothionein gene expression by hypoxia involves metal response elements and metal transcription factor-1. Cancer Res. 59:1315–1322. 1999.PubMed/NCBI
28	Günther V, Lindert U and Schaffner W: The taste of heavy metals: gene regulation by MTF-1. Biochim Biophys Acta. 1823:1416–1425. 2012. View Article : Google Scholar : PubMed/NCBI
29	Paonessa G, Gounari F, Frank R and Cortese R: Purification of a NF1-like DNA-binding protein from rat liver and cloning of the corresponding cDNA. EMBO J. 7:3115–3123. 1988.PubMed/NCBI
30	Rupp RA, Kruse U, Multhaup G, Göbel U, Beyreuther K and Sippel AE: Chicken NFI/TGGCA proteins are encoded by at least three independent genes: NFI-A, NFI-B and NFI-C with homologues in mammalian genomes. Nucleic Acids Res. 18:2607–2616. 1990. View Article : Google Scholar : PubMed/NCBI
31	Meisterernst M, Rogge L, Foeckler R, Karaghiosoff M and Winnacker EL: Structural and functional organization of a porcine gene coding for nuclear factor I. Biochemistry. 28:8191–8200. 1989. View Article : Google Scholar : PubMed/NCBI
32	Majumder S, Ghoshal K, Gronostajski RM and Jacob ST: Downregulation of constitutive and heavy metal-induced metallothionein-I expression by nuclear factor I. Gene Expr. 9:203–215. 2001.PubMed/NCBI
33	Jacob ST, Majumder S and Ghoshal K: Suppression of metallothionein-I/II expression and its probable molecular mechanisms. Environ Health Perspect. 110(Suppl 5): 827–830. 2002. View Article : Google Scholar : PubMed/NCBI
34	Tang CM, Westling J and Seto E: trans repression of the human metallothionein IIA gene promoter by PZ120, a novel 120-kilo-dalton zinc finger protein. Mol Cell Biol. 19:680–689. 1999.
35	Datta J, Majumder S, Bai S, et al: Physical and functional interaction of DNA methyltransferase 3A with Mbd3 and Brg1 in mouse lymphosarcoma cells. Cancer Res. 65:10891–10900. 2005. View Article : Google Scholar : PubMed/NCBI
36	Yin H, Smith M and Glass J: Stable expression of C/EBPalpha in prostate cancer cells down-regulates metallothionein and increases zinc-induced toxicity. Prostate. 62:209–216. 2005. View Article : Google Scholar
37	Ghoshal K, Li Z and Jacob ST: Overexpression of the large subunit of the protein Ku suppresses metallothionein-I induction by heavy metals. Proc Natl Acad Sci USA. 95:10390–10395. 1998. View Article : Google Scholar : PubMed/NCBI
38	Majumder S, Kutay H, Datta J, Summers D, Jacob ST and Ghoshal K: Epigenetic regulation of metallothionein-i gene expression: differential regulation of methylated and unmethylated promoters by DNA methyltransferases and methyl CpG binding proteins. J Cell Biochem. 97:1300–1316. 2006. View Article : Google Scholar
39	Koschmieder S, Halmos B, Levantini E and Tenen DG: Dysregulation of the C/EBPalpha differentiation pathway in human cancer. J Clin Oncol. 27:619–628. 2009. View Article : Google Scholar :
40	Majumder S, Ghoshal K, Li Z and Jacob ST: Hypermethylation of metallothionein-I promoter and suppression of its induction in cell lines overexpressing the large subunit of Ku protein. J Biol Chem. 274:28584–28589. 1999. View Article : Google Scholar : PubMed/NCBI
41	Mao J, Yu H, Wang C, et al: Metallothionein MT1M is a tumor suppressor of human hepatocellular carcinomas. Carcinogenesis. 33:2568–2577. 2012. View Article : Google Scholar : PubMed/NCBI
42	Compere SJ and Palmiter RD: DNA methylation controls the inducibility of the mouse metallothionein-I gene lymphoid cells. Cell. 25:233–240. 1981. View Article : Google Scholar : PubMed/NCBI
43	Arriaga JM, Levy EM, Bravo AI, et al: Metallothionein expression in colorectal cancer: relevance of different isoforms for tumor progression and patient survival. Hum Pathol. 43:197–208. 2012. View Article : Google Scholar
44	Faller WJ, Rafferty M, Hegarty S, et al: Metallothionein 1E is methylated in malignant melanoma and increases sensitivity to cisplatin-induced apoptosis. Melanoma Res. 20:392–400. 2010.PubMed/NCBI
45	Peng D, Hu TL, Jiang A, et al: Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas. PLoS One. 6:e220092011. View Article : Google Scholar : PubMed/NCBI
46	Rosenbauer F, Wagner K, Kutok JL, et al: Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet. 36:624–630, Epub 2004 May 2016. 2004. View Article : Google Scholar : PubMed/NCBI
47	Pettersson M, Sundström C, Nilsson K and Larsson LG: The hematopoietic transcription factor PU.1 is downregulated in human multiple myeloma cell lines. Blood. 86:2747–2753. 1995.PubMed/NCBI
48	Inoue K and Takano H: Metallothionein as a negative regulator of pulmonary inflammation. Curr Pharm Biotechnol. 14:414–419. 2013. View Article : Google Scholar : PubMed/NCBI
49	Mocchegiani E, Costarelli L, Basso A, Giacconi R, Piacenza F and Malavolta M: Metallothioneins, ageing and cellular senescence: a future therapeutic target. Curr Pharm Des. 19:1753–1764. 2013.
50	Hirako N, Nakano H and Takahashi S: A PU.1 suppressive target gene, metallothionein 1G, inhibits retinoic acid-induced NB4 cell differentiation. PLoS One. 9:e1032822014. View Article : Google Scholar : PubMed/NCBI